Serina Therapeutics (SER) Tax Provisions (2019)
Serina Therapeutics' (SER) quarterly Tax Provisions came in at $18000.0 in Q4 2019, down 66.67% quarter-over-quarter from $54000.0 in Q3 2019.
Powered by 
Analysis
Serina Therapeutics (SER) Tax Provisions (2019) Analysis & Trends
Serina Therapeutics has disclosed Tax Provisions across 1 years of filings, most recently posting $18000.0 for Q4 2019.
- In Q4 2019, Tax Provisions changed N/A year-over-year to $18000.0; the TTM figure through Dec 2019 stood at $148000.0 (changed N/A YoY), while the FY2025 annual figure was $18000.0, changed N/A from the prior year.
- Tax Provisions came in at $18000.0 for Q4 2019 at Serina Therapeutics, down from $54000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $73000.0 in Q1 2019 to a low of $3000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 54,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 73,000.00 |